aldosterone has been researched along with Local Neoplasm Recurrence in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To elucidate the combined effects of fadrozole (nonsteroidal aromatase inhibitor) and tamoxifen, 11 postmenopausal patients with recurrent breast cancer were examined between October 1996 and June 1998." | 9.09 | [A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen]. ( Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T, 2000) |
| "Imaging with [¹²³I]iodometomidate ([¹²³I]IMTO) has been shown to diagnose adrenocortical lesions with high sensitivity and specificity." | 7.79 | [¹²³I]Iodometomidate imaging in adrenocortical carcinoma. ( Allolio, B; Bock, S; Buck, AK; Fassnacht, M; Haenscheid, H; Hahner, S; Knoedler, P; Kreissl, MC; Reiners, C; Saeger, W; Schirbel, A; Verburg, FA, 2013) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Primary aldosteronism was confirmed by using the oral sodium-loading test." | 5.43 | Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate. ( Chiu, PW; Chow, FC; Chu, CC; Kong, AP; Liu, SY; Ng, EK; Tsui, TK; Wong, SK, 2016) |
| "To elucidate the combined effects of fadrozole (nonsteroidal aromatase inhibitor) and tamoxifen, 11 postmenopausal patients with recurrent breast cancer were examined between October 1996 and June 1998." | 5.09 | [A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen]. ( Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T, 2000) |
| "Imaging with [¹²³I]iodometomidate ([¹²³I]IMTO) has been shown to diagnose adrenocortical lesions with high sensitivity and specificity." | 3.79 | [¹²³I]Iodometomidate imaging in adrenocortical carcinoma. ( Allolio, B; Bock, S; Buck, AK; Fassnacht, M; Haenscheid, H; Hahner, S; Knoedler, P; Kreissl, MC; Reiners, C; Saeger, W; Schirbel, A; Verburg, FA, 2013) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Primary aldosteronism (PA) patients diagnosed with aldosterone-producing adenoma and unilateral adrenal hyperplasia are preferred for surgical treatment." | 1.62 | [Controversy and strategy of partial versus total adrenalectomy in the treatment of primary aldosteronism]. ( Liu, G; Luo, GH, 2021) |
| "BACKGROUND Primary aldosteronism, also known as Conn's syndrome, is a clinical condition caused by excessive production of aldosterone." | 1.62 | Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases. ( Chen, CT; Lin, CM; Wang, YC, 2021) |
| "A subgroup of ERα-positive breast cancer is characterized by mosaic presence of a minor population of ERα-negative cancer cells expressing the basal cytokeratin-5 (CK5)." | 1.43 | Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. ( Girondo, MA; Goodman, CR; Hooke, JA; Hyslop, T; Kovatich, AJ; Liu, C; Mitchell, EP; Peck, AR; Rui, H; Sato, T; Shriver, CD; Yanac, AF; Yang, N, 2016) |
| "Primary aldosteronism was confirmed by using the oral sodium-loading test." | 1.43 | Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate. ( Chiu, PW; Chow, FC; Chu, CC; Kong, AP; Liu, SY; Ng, EK; Tsui, TK; Wong, SK, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, GH | 1 |
| Liu, G | 1 |
| Jiang, HF | 1 |
| Tian, XM | 1 |
| Ma, W | 1 |
| Shi, QL | 1 |
| Lu, P | 1 |
| Liu, F | 1 |
| Liu, X | 1 |
| He, DW | 1 |
| Lin, T | 1 |
| Wei, GH | 1 |
| Chen, CT | 1 |
| Wang, YC | 1 |
| Lin, CM | 1 |
| Kreissl, MC | 1 |
| Schirbel, A | 1 |
| Fassnacht, M | 1 |
| Haenscheid, H | 1 |
| Verburg, FA | 1 |
| Bock, S | 1 |
| Saeger, W | 1 |
| Knoedler, P | 1 |
| Reiners, C | 1 |
| Buck, AK | 1 |
| Allolio, B | 1 |
| Hahner, S | 1 |
| Goodman, CR | 1 |
| Sato, T | 1 |
| Peck, AR | 1 |
| Girondo, MA | 1 |
| Yang, N | 1 |
| Liu, C | 1 |
| Yanac, AF | 1 |
| Kovatich, AJ | 1 |
| Hooke, JA | 1 |
| Shriver, CD | 1 |
| Mitchell, EP | 1 |
| Hyslop, T | 1 |
| Rui, H | 1 |
| Liu, SY | 1 |
| Chu, CC | 1 |
| Tsui, TK | 1 |
| Wong, SK | 1 |
| Kong, AP | 1 |
| Chiu, PW | 1 |
| Chow, FC | 1 |
| Ng, EK | 1 |
| Carmona-Bayonas, A | 1 |
| Soler, IO | 1 |
| Gómez, FI | 1 |
| Billalabeitia, EG | 1 |
| Saura, HP | 1 |
| Tafalla, MS | 1 |
| Díaz, MP | 1 |
| Calvo-Romero, JM | 1 |
| Ramos-Salado, JL | 1 |
| Tominaga, T | 1 |
| Kimura, M | 1 |
| Toge, T | 1 |
| Takashima, S | 1 |
| Nomura, Y | 1 |
| Ohashi, Y | 1 |
| Santen, RJ | 1 |
| Samojlik, E | 1 |
| Lipton, A | 1 |
| Harvey, H | 1 |
| Ruby, EB | 1 |
| Wells, SA | 1 |
| Kendall, J | 1 |
| Miyazaki, G | 1 |
| Sasano, N | 1 |
| Torikai, T | 1 |
| Fukuchi, S | 1 |
2 reviews available for aldosterone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Practice status and influencing factors of adrenalectomy in patients with Wilms tumor.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Carcinoma, Renal C | 2023 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
1 trial available for aldosterone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; | 2000 |
8 other studies available for aldosterone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Controversy and strategy of partial versus total adrenalectomy in the treatment of primary aldosteronism].
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Neoplasm Recurrence | 2021 |
Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases.
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; M | 2021 |
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aldosterone; Cohort | 2013 |
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
Topics: Aldosterone; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; | 2016 |
Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Biomarkers, Tumor; Catheter Ablation; | 2016 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang | 2007 |
Recurrence of adrenal aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Female; Humans; Middle Aged; Neoplasm | 2000 |
Adrenocortical carcinoma with an isolated mineralocorticoid excess and recurrency fourteen years after removal of the tumor.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Humans; Hydrocortisone; Hypertension; M | 1973 |